You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

panobinostat

Showing 1 - 25 of 68
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Melanoma, Skin Cancer Trial in Tampa (Panobinostat, Ipilimumab)

Completed
Has Results
  • Melanoma
  • Skin Cancer
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Jan 18, 2023

Diffuse Intrinsic Pontine Glioma, Pediatric Brainstem Glioma, Pediatric Brainstem Gliosarcoma, Recurrent Trial in Boston

Active, not recruiting
  • Diffuse Intrinsic Pontine Glioma
  • +5 more
  • Boston, Massachusetts
  • +1 more
May 3, 2022

Rhabdoid Tumor, Atypical Teratoid/Rhabdoid Tumor, Malignant Rhabdoid Tumor Trial in Australia, New Zealand, United States

Terminated
  • Rhabdoid Tumor
  • +3 more
  • Panobinostat
  • Durham, North Carolina
  • +10 more
Jun 5, 2022

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Seattle (Carfilzomib, Chemosensitivity Assay,

Terminated
Has Results
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
May 6, 2022

Multiple Myeloma Trial in United States (panobinostat, carfilzomib)

Completed
Has Results
  • Multiple Myeloma
  • Denver, Colorado
  • +12 more
Jan 4, 2022

Plasma Cell Leukemia, Plasmacytoma, Recurrent Plasma Cell Myeloma Trial in Houston (procedure, drug, other)

Active, not recruiting
  • Plasma Cell Leukemia
  • +3 more
  • Autologous Hematopoietic Stem Cell Transplantation
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 6, 2022

Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer Trial in Buffalo, Rochester

Terminated
Has Results
  • Clear Cell Renal Cell Carcinoma
  • +3 more
  • panobinostat
  • +7 more
  • Buffalo, New York
  • +1 more
Aug 11, 2022

Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in

Completed
Has Results
  • Adult Nasal Type Extranodal NK/T-cell Lymphoma
  • +20 more
  • panobinostat
  • +6 more
  • Scottsdale, Arizona
  • +1 more
May 6, 2022

GVHD, GVHD Trial in Tampa (Panobinostat, Sirolimus, Tacrolimus)

Completed
Has Results
  • Graft Versus Host Disease
  • GVHD
  • Panobinostat
  • +2 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Jul 19, 2021

Multiple Myeloma in Relapse Trial in Boston, Durham (Panobinostat, Dexamethasone, Lenalidomide)

Completed
  • Multiple Myeloma in Relapse
  • Panobinostat
  • +3 more
  • Boston, Massachusetts
  • +3 more
Sep 3, 2021

Sickle Cell Disease Trial in Augusta (panobinostat)

Active, not recruiting
  • Sickle Cell Disease
  • panobinostat
  • Augusta, Georgia
    Augusta University
May 26, 2021

Metastatic Colorectal Cancer Trial in Oslo (Alectinib, Cetuximab, Crizotinib)

Recruiting
  • Metastatic Colorectal Cancer
  • Oslo, Norway
    Oslo University Hospital
Feb 10, 2023

Acute Myeloid Leukaemia (AML), MDS (MDS) Trial in Germany, Netherlands (Panobinostat)

Active, not recruiting
  • Acute Myeloid Leukaemia (AML)
  • Myelodysplastic Syndromes (MDS)
  • Panobinostat
  • Stuttgart, Baden-Württemberg, Germany
  • +18 more
Dec 13, 2021

Primary Myelofibrosis, Post-Polycythemia Vera, Post-Essential Thrombocytopenia Trial in United States (Panobinostat)

Terminated
Has Results
  • Primary Myelofibrosis
  • +2 more
  • Panobinostat
  • Scottsdale, Arizona
  • +8 more
Jul 9, 2021

Colorectal Cancer, Non-small Cell Lung Carcinoma (Adenocarcinoma), Triple Negative Breast Cancer, Renal Cell Carcinoma Trial in

Completed
  • Colorectal Cancer, Non-small Cell Lung Carcinoma (Adenocarcinoma), Triple Negative Breast Cancer, Renal Cell Carcinoma
  • PDR001
  • +5 more
  • Santa Monica, California
  • +24 more
Mar 11, 2022

Idiopathic Myelofibrosis, Post Essential Thrombocythemia Myelofibrosis, Post Polycythemia-Vera Myelofibrosis Trial in Worldwide

Completed
  • Idiopathic Myelofibrosis
  • +2 more
  • Paris, France
  • +9 more
Jun 22, 2021

Hodgkin's Lymphoma Trial in Houston (Panobinostat, Ifosfamide, Mesna)

Completed
Has Results
  • Hodgkin's Lymphoma
  • Panobinostat
  • +5 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Dec 10, 2020

MDS (MDS), Chronic Myelomonocytic Leukemia (CMML), Acute Myeloid Leukemia (AML) Trial in Japan (Panobinostat)

Completed
  • Myelodysplastic Syndromes (MDS)
  • +2 more
  • Panobinostat
  • Nagoya-city, Aichi, Japan
  • +5 more
Dec 16, 2020

MDS (MDS) Trial in United States (Panobinostat)

Terminated
Has Results
  • Myelodysplastic Syndromes (MDS)
  • Panobinostat
  • Fort Myers, Florida
  • +6 more
Nov 18, 2021

Acute Myeloid Leukemia (AML) Trial in Germany, Spain, United States (Panobinostat)

Completed
  • Acute Myeloid Leukemia (AML)
  • Panobinostat
  • Stanford, California
  • +9 more
Dec 16, 2020

Classical Hodgkin's Lymphoma Trial in Worldwide (Panobinostat)

Completed
Has Results
  • Classical Hodgkin's Lymphoma
  • Panobinostat
  • Duarte, California
  • +45 more
Jul 26, 2021

Hematologic Tumors Trial in Worldwide (Panobinostat)

Completed
Has Results
  • Hematologic Neoplasms
  • Panobinostat
  • Duarte, California
  • +6 more
Nov 18, 2019

Multiple Myeloma, Kahler Disease, Plasma-Cell Myeloma Trial in Cleveland (Panobinostat, Dexamethasone, MLN9708)

Completed
Has Results
  • Multiple Myeloma
  • +3 more
  • Panobinostat
  • +2 more
  • Cleveland, Ohio
  • +1 more
Dec 10, 2019

Melanoma, Non Small Cell Lung Cancer Trial (PDR001, Panobinostat)

Withdrawn
  • Melanoma
  • Non Small Cell Lung Cancer
  • (no location specified)
Oct 1, 2019

Multiple Myeloma Trial in Worldwide (Panobinostat)

No longer available
  • Multiple Myeloma
  • Panobinostat
  • Innsbruck, Tyrol, Austria
  • +39 more
Apr 6, 2020